Jing Tian–Justin Sun Lawsuit Fact-Check: Surrogacy Rumours, Civil Law and Ethics

Findings and evidence levels

On 27 August 2026, Justin Sun's lawyer Zhang Qihuai publicly said that Sun had sued actress Jing Tian and her parents, seeking the return of more than RMB 30 million and applying for asset preservation. Zhang said the case had been filed with the Yanta District People's Court in Xi'an and that Jing's side had raised a territorial-jurisdiction objection. Public material available on 29 August did not show that the court had begun hearing the merits or issued a final judgment.

The same day's essay My Girlfriend Jing Tian and an earlier image described online as a “surrogacy agreement” included claims about egg retrieval, an overseas agency and a surrogacy arrangement. No independent evidence or judicial finding substantiates those claims. The essay itself ended with a fiction disclaimer, and Jing Tian's studio rejected the rumours in May and again in August. Although Sun's lawyer later told an interviewer that “the surrogacy is also a fact,” that remains a statement by one side's representative, not a court finding.

Procedural status and public responses

The public timeline has four material points:

In an interview, Zhang Qihuai said that the filing was made in the Yanta District People's Court, that the defendants had challenged territorial jurisdiction and that no hearing date had been set. He also said asset preservation had been requested but not yet ruled upon. The time needed to resolve jurisdiction and the court that will ultimately hear the merits should be taken from later court documents.

This distinction controls the headline. “Bride-price lawsuit,” “surrogacy rumour” and “an essay containing surrogacy claims” are defensible descriptions. “Surrogacy exposed as fact” or “court confirms surrogacy” would convert untested allegations into certainty.

Bride price, gifts and a fiction disclaimer

The claimant characterises the transfers as a marriage-related “bride price.” A court determines their legal nature from the background to the transfers, marriage intentions, the relationship, actual use of the money, messages and other evidence. A large transfer between parents may be a bride price, an ordinary gift or another property arrangement. The payer's label alone is not decisive.

The Supreme People's Court rules effective from 1 February 2024 state that when a couple did not register a marriage but lived together, a court should consider actual use of the bride price, dowry, cohabitation, pregnancy or children, fault and local custom when deciding whether anything should be returned and in what proportion. Lack of registration does not automatically require a full refund.

The same rules allow a person to the intended marriage and parents who actually paid the bride price to be co-claimants, and allow the other person and parents who actually received it to be co-defendants. That explains why parents may appear in the proceedings; it does not pre-judge the character of the transfers or the refund amount.

A “fiction” label is not automatic immunity. Liability can depend on whether readers can identify a real person, whether the publication insults or defames, whether medical or relationship privacy is exposed, the scale of circulation and provable loss. Even truthful private information is not automatically available for unlimited public disclosure.

The legal boundary in mainland China

Mainland China has no statute establishing a lawful surrogacy framework. Article 3 of the Measures for the Administration of Human Assisted Reproductive Technology states that medical institutions and medical personnel may not perform any form of surrogacy technology. It directly regulates providers and staff; it cannot, by itself, establish that every intended parent commits a criminal offence. Individual liability still depends on conduct, evidence and other applicable law.

Public court-education material generally treats surrogacy contracts as invalid for violating public order and good morals. Invalidity does not make every financial, parentage, tort or identity issue disappear. Those consequences must still be handled separately.

The material differences are whose gametes are used and who carries the pregnancy. Collapsing retrieval, oocyte donation and surrogacy into one label distorts both medical risk and legal responsibility.

Forms of surrogacy and the parties involved

Gestational surrogacy uses an embryo created from the intended parents' or donors' gametes; the carrier usually has no genetic link to the child. Traditional surrogacy uses the carrier's own oocyte, combining genetic and gestational roles and increasing potential parentage conflict.

Legal models also differ. Commercial surrogacy permits compensation beyond expenses; altruistic systems generally permit reasonable expenses only; jurisdictions with no dedicated law may provide neither clear access nor reliable parentage, registration and remedy rules. A lower price or the absence of an explicit prohibition is not equivalent to statutory protection.

A cross-border programme can involve the intended parent or parents, gestational carrier, gamete providers, clinic and embryology laboratory, an intermediary or coordinator, counsel in the place of birth, counsel in the destination state, civil registry, consular office and immigration authority. An “all-inclusive” promise matters only if the identity, responsibility, payee, documents and exit mechanism for each participant can be verified.

Medical risks of retrieval and pregnancy

Egg retrieval is not a single blood test. A typical sequence includes early-cycle assessment, roughly 10–14 days of controlled ovarian stimulation, repeated hormone and ultrasound monitoring, a maturation trigger and ultrasound-guided transvaginal retrieval about 36 hours later. Retrieval is usually performed with sedation or anaesthesia but remains invasive. Potential complications include bleeding, infection, anaesthetic events and ovarian hyperstimulation syndrome (OHSS).

OHSS risk varies with protocol, ovarian response, trigger and pregnancy. Older publications report broad ranges that combine different degrees of severity and should not be treated as one current probability. Ireland's 2025 national IVF/ICSI guideline cites European monitoring in which reported hospital admission for OHSS was 0.16% in 2019, down from 0.3% in 2010, while warning that ART complications may be under-reported. This page therefore does not retain the source document's single “0.6%–14% overall” figure as a current risk estimate.

A gestational carrier bears risks across pregnancy and birth, including hypertensive disorders, gestational diabetes, placenta praevia, postpartum haemorrhage, caesarean delivery and the additional risk of multiple pregnancy. ASRM's ethics opinion states that the carrier retains authority over prenatal testing, multifetal reduction, pregnancy termination, delivery and aftercare. A contract cannot transfer that medical authority to intended parents or an intermediary.

Legal movement from 2024 to 2026

There is no uniform global surrogacy law. Recent changes include restriction, regulated access and protection of a child's post-birth status:

International documents do not speak with one voice. UNICEF emphasises the identity, nationality, family-relations, health and anti-sale rights of every child born through surrogacy. UN special rapporteurs have approached surrogacy through sale-of-children, violence and exploitation frameworks. ASRM concludes that gestational-carrier arrangements can be ethically permissible when there is adequate medical, psychological and legal assessment, carrier autonomy and no coercion. These sources answer different questions and cannot be reduced to “the UN or medicine supports/opposes surrogacy.”

Ethical arguments and limits of research

Arguments against commercial surrogacy include commodification, consent under economic pressure, information asymmetry, positioning a child within a transaction and conflict over parentage. Arguments for permission or regulation emphasise reproductive autonomy, informed consent by adults, the possibility of altruistic arrangements and safeguards such as independent counsel, compensation rules and medical autonomy.

Longitudinal research supplies useful observations but cannot settle the ethics. The seventh phase of the UK Longitudinal Study of Assisted Reproduction Families followed participants at age 20. A 2023 Human Reproduction paper included 35 young adults who knew how they were conceived, 15 of whom were born through surrogacy. Most of the surrogacy-born participants described neutral or positive feelings. This is a small UK cohort and cannot represent every commercial or cross-border arrangement.

A separate 2024 Human Reproduction study revisited UK surrogates roughly two decades later. It recorded many positive experiences while also discussing repeat pregnancies, changes in relationships and selection limitations. These studies show that outcomes are not singular; they do not prove either that surrogacy is free of psychological risk or that trauma is inevitable.

Carrier safeguards and the child's identity

An auditable arrangement should give the carrier independent legal counsel, complete documents in a language she understands, independent psychological support, full medical disclosure, fair expense or compensation rules and authority over her medical care. ASRM advises against proceeding where there is financial or emotional coercion, inability to give informed consent, or serious disagreement over reduction or termination decisions.

The child's status must be divided into five questions:

An apostille generally authenticates the origin of a public document and its signature or seal. It does not determine parentage, nationality, passport eligibility, entry or residence.

Checks before payment or treatment

Pause payment or treatment when a provider asks anyone to conceal surrogacy, oocyte donation or genetic relationships; company, clinic, physician or lawyer identities cannot be verified; only screenshots or oral translations are supplied; “guaranteed success” or “a birth certificate guarantees citizenship” replaces an authority's written answer; a large payment is demanded before the medical plan, exit terms and independent legal opinions exist; a contract attempts to control the carrier's medical decisions; or complications, termination and unused balances are left unexplained.

Conclusion and limits

What can presently be confirmed is a civil property dispute at a procedural stage and a series of public statements. Whether the transfers were a bride price, whether anything must be returned and in what proportion are questions for the court on the evidence. Claims about surrogacy, egg retrieval and overseas agencies have no independent corroboration or judicial finding and should not be upgraded from a trending topic, unilateral essay or lawyer interview into fact.

The surrogacy issues remain worthy of public discussion, but that discussion should move away from personal rumour and toward verifiable questions: who bears medical risk, who controls medical decisions, how a child's status is secured, who is accountable for contracts and payments, and what happens when law or circumstances change.